FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
7237811000172118 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


15419 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Recombinant antihemophilic factor agent 500iu powder for injection solution vial Product containing precisely octocog alfa 500 international unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant coagulation factor IX 1000iu powder and solvent for injection solution vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 1000iu powder for conventional release solution for injection vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 1000iu powder for injection solution vial Nonacog alfa 1000 international unit powder for solution for injection vial
Recombinant coagulation factor IX 250iu powder and solvent for injection solution vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 250iu powder for conventional release solution for injection vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 250iu powder for injection solution vial Nonacog alfa 250 international unit powder for solution for injection vial
Recombinant coagulation factor IX 500iu powder and solvent for injection solution vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 500iu powder for conventional release solution for injection vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 500iu powder for injection solution vial Nonacog alfa 500 international unit powder for solution for injection vial
Recombinant coagulation factor VIIa 120,000iu powder and solvent for injection solution vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 120,000iu powder for conventional release solution for injection vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 240,000iu powder and solvent for injection solution vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 240,000iu powder for conventional release solution for injection vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 60,000iu powder and solvent for injection solution vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 60,000iu powder for conventional release solution for injection vial Coagulation factor VIIa only product in parenteral dose form
Recombinant human follicle stimulating hormone alfa 150iu/lutropin alfa 75iu powder and solvent for injection solution vial Product containing only follitropin alfa and lutropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon) Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 150iu powder and solvent for injection solution ampule Follitropin alfa 300 unit/mL solution for injection
Recombinant human follicle stimulating hormone alpha 37.5iu powder for conventional release solution for injection ampule Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug)
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon) Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon)+diluent Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 75iu powder and solvent for injection solution ampule Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant parathyroid hormone 100micrograms powder for injection solution cartridge and solvent Recombinant parathyroid hormone only product
Recombinant thrombin 20000iu powder for conventional release cutaneous solution Product containing only thrombin in cutaneous dose form (medicinal product form)
Recombinant thrombin 20000iu powder for topical solution + 20mL prefilled syringe diluent Product containing only thrombin in cutaneous dose form (medicinal product form)
Recombinant thrombin 5000iu powder for conventional release cutaneous solution Product containing only thrombin in cutaneous dose form (medicinal product form)
Recombinant thrombin 5000iu powder for topical solution + 5mL prefilled syringe diluent Product containing only thrombin in cutaneous dose form (medicinal product form)
operatief herstel en opnieuw verbinden van ureter Anastomosis of ureter
Reconstruction of breast using distant flap of skin NEC Reconstruction of breast using distant skin flap
Reconstruction of jaw using pedicled bone flap Reconstruction of mandible using bone flap (procedure)
Reconstruction of organ NOC Reconstruction procedure
Reconstruction of urinary bladder Urinary bladder reconstruction
reconstructie met voorhoofdslap Reconstruction using flap from forehead (procedure)
Recreational therapy Recreational therapy
Rectal prednisolone preparations allergy Allergy to prednisolone
Rectus muscle sprain Strain of rectus abdominus muscle (disorder)
Recurrent dislocation of other site, NEC Recurrent dislocation of joint
Recurrent hernia Herniated structure (morphologic abnormality)
Recurrent mouth ulcers Recurrent ulcer of mouth (disorder)
Red blood cell shape NOS Red blood cell shape
Red blood cell shape NOS Red blood cell shape
rougeur Red color (qualifier value)
Red color Red color (qualifier value)
œil rouge Red eye
Reductase Reductase
Redundant prepuce AND/OR phimosis Redundant prepuce and phimosis
re-excisie Excision
Refer for imaging NOS Referral for imaging
Refer for imaging NOS Referral for imaging
verwijzen naar afdeling psychiatrie bij verstandelijke handicap Referral to intellectual disability psychiatry service
Referral to microenterprise development organization Referral to microenterprise development program (procedure)
verwijzen naar psychiater voor verstandelijke handicap Referral to intellectual disability psychiatrist (procedure)
Referring organization Referring organization (observable entity)
Reflex sympathetic dystrophy of lower extremity Complex regional pain syndrome of lower limb (disorder)
Reflex sympathetic dystrophy of upper extremity Complex regional pain syndrome of upper limb (disorder)
Refractory Intractable
Refractory anaemia Myelodysplastic syndrome with low blasts (disorder)
Refractory anemia Myelodysplastic syndrome with low blasts (disorder)
Refractory anemia Myelodysplastic neoplasm with low blasts (morphologic abnormality)
refractaire anemie Myelodysplastic neoplasm with low blasts (morphologic abnormality)
Refractory anaemia with excess blasts (clinical) Subacute leukemia
Refractory anemia with excess blasts in transformation Acute myeloid leukemia with myelodysplasia-related changes (disorder)
anémie réfractaire avec excès de blastes en transformation Acute myeloid leukemia with myelodysplasia-related changes (disorder)
myelodysplastisch syndroom met overmaat aan blasten in transformatie Myelodysplastic syndrome with increased blasts (morphologic abnormality)
Refractory anemia with excess of blasts Myelodysplastic syndrome with increased blasts (morphologic abnormality)
Refractory anemia with excess of blasts with transformation Acute myeloid leukemia with myelodysplasia-related changes (disorder)
Refractory anemia with excess of blasts with transformation Myelodysplastic syndrome with excess blasts (disorder)
Refractory anemia with ringed sideroblasts Myelodysplastic neoplasm with low blasts and SF3B1 mutation
Refractory anemia with ringed sideroblasts (morphologic abnormality) Myelodysplastic neoplasm with low blasts and SF3B1 mutation
Refractory anemia with sideroblasts Myelodysplastic neoplasm with low blasts and SF3B1 mutation
Refractory anemia without sideroblasts Myelodysplastic neoplasm with low blasts (morphologic abnormality)
anémie réfractaire sans sidéroblastes Myelodysplastic syndrome with low blasts (disorder)
Refractory cytopenia with multilineage dysplasia and ringed sideroblasts Myelodysplastic neoplasm with low blasts and SF3B1 mutation
Refractory cytopenia with unilineage dysplasia Myelodysplastic neoplasm with low blasts (morphologic abnormality)
refractaire neutropenie Myelodysplastic syndrome with low blasts (disorder)
refractaire neutropenie Myelodysplastic neoplasm with low blasts (morphologic abnormality)
refractaire parodontitis Periodontitis
refractaire trombocytopenie Myelodysplastic syndrome with low blasts (disorder)
behandeling geweigerd door ouders Refused procedure - parent's wish
Refused by parents of subject Refused by parent of subject (qualifier value)
Refused new patient screening New patient screening declined (situation)
Refused new patient screening New patient screening declined (situation)
Refuses asthma monitoring Asthma monitoring declined (situation)
Refuses asthma monitoring Asthma monitoring declined (situation)
Refuses geriatric monitoring Geriatric monitoring declined
Refuses geriatric monitoring Geriatric monitoring declined
Refuses hormone replacement monitoring Monitoring of hormone replacement therapy declined
Refuses hormone replacement monitoring Monitoring of hormone replacement therapy declined
Refuses hypertension monitoring Hypertension monitoring declined
Refuses hypertension monitoring Hypertension monitoring declined
Refuses obesity monitoring Obesity monitoring declined
Refuses obesity monitoring Obesity monitoring declined
Refuses osteoporosis monitoring Osteoporosis monitoring declined
Refuses osteoporosis monitoring Osteoporosis monitoring declined
Refuses osteoporosis monitoring Osteoporosis monitoring declined
Refuses osteoporosis monitoring Osteoporosis monitoring declined
Refuses stop smoking monitor Monitoring of smoking cessation therapy declined
Refuses stop smoking monitor Monitoring of smoking cessation therapy declined
Refuses stress monitoring Monitoring for stress declined

Start Previous Page 109 of 155 Next End


Reference Sets

Reference set descriptor

Back to Start